# Cyanotech Corp

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/Cyanotech Corp).

## Overview

Cyanotech Corp is a U.S.-based producer of microalgae-derived nutritional ingredients and finished supplements, built around Hawaiian Spirulina Pacifica and BioAstin Hawaiian Astaxanthin. The company grows, harvests, processes, and sells spirulina and astaxanthin in bulk form to ingredient customers and in packaged consumer form through its Nutrex Hawaii subsidiary. It also monetizes its extraction expertise through contract extraction services and, more recently, third-party R&D services. Cyanotech’s business is tied to its Kona, Hawaii production site, where climate, cultivation conditions, and production volume directly affect output, quality, and margins.

## Products & services

• Hawaiian Spirulina Pacifica bulk powder and tablets
• BioAstin Hawaiian Astaxanthin ingredients and supplements
• Packaged consumer products via Nutrex Hawaii
• Contract extraction services for astaxanthin biomass
• Third-party microalgae R&D services
• Private-label / distributor-oriented bulk ingredient sales

- **Bulk spirulina ingredients** (30%) — Hawaiian Spirulina Pacifica sold as powder or tablets to manufacturers and formulators.
- **Bulk astaxanthin ingredients** (40%) — BioAstin-related astaxanthin sales in bulk form for use in customer products.
- **Packaged consumer supplements** (23%) — Finished spirulina and astaxanthin products sold through retail, online, and distributor channels.
- **Contract extraction services** (4%) — Supercritical CO2 extraction services provided to third-party biomass producers.
- **Research and development services** (3%) — Microalgae-related R&D services offered to third parties using excess capacity and know-how.

- Hawaiian Spirulina Pacifica bulk powder and tablets
- BioAstin Hawaiian Astaxanthin products
- Packaged consumer supplements sold through Nutrex Hawaii
- Contract extraction services for third-party astaxanthin biomass
- Third-party microalgae research and development services
- Bulk ingredient sales to health food manufacturers and formulators

## Customers

Cyanotech sells bulk ingredients primarily to international health food manufacturers, formulators, and other producers that incorporate spirulina or astaxanthin into their own branded products. Its packaged consumer products are sold through natural product distributors, retailers, online channels, and direct-to-consumer channels, mainly under the Nutrex Hawaii brand. The company also serves third-party biomass producers that need extraction capacity, as well as customers seeking microalgae R&D support. Customer concentration is meaningful, with a small number of accounts accounting for a large share of annual sales, so procurement changes by major customers can materially affect revenue.

- **Bulk ingredient manufacturers and formulators** (primary) — Buy spirulina and astaxanthin ingredients to incorporate into their own health and nutrition products, often because they value Hawaiian sourcing and product quality.
- **Packaged supplement consumers** (primary) — Purchase finished spirulina and astaxanthin products through retail, e-commerce, and direct channels for wellness and nutritional use.
- **International distributors** (secondary) — Distribute Cyanotech-branded or customer-branded products in selected overseas markets where local channel partners are used.
- **Contract extraction customers** (secondary) — Third-party biomass producers that outsource extraction to Cyanotech’s supercritical CO2 system.
- **R&D service customers** (emerging) — Third parties seeking microalgae cultivation and processing expertise for development work.

- International health food manufacturers buying bulk spirulina for private-label use
- Formulators and ingredient buyers seeking Hawaiian-origin spirulina and astaxanthin
- Natural product retailers and distributors selling Nutrex Hawaii supplements
- Online and direct-to-consumer supplement shoppers
- Third-party astaxanthin biomass producers using contract extraction capacity
- Customers needing microalgae R&D support and technical know-how

## Geography

Cyanotech is headquartered and produces in Hawaii, with its core cultivation and processing operations centered at its Kona facility. The company also relies on third-party bottling and labeling contractors in California for packaged consumer products. Sales are global in nature: management disclosed that 21% of fiscal 2025 revenue and 18% of fiscal 2024 revenue came from outside the United States. Geography matters because the business depends on Hawaii’s climate and water conditions for algae cultivation, while international sales expose the company to foreign demand trends, local regulations, and distributor relationships.

- **United States** (79%) — Derived from management disclosure that 21% of fiscal 2025 revenue came from outside the U.S.
- **International** (21%) — Management disclosed 21% of fiscal 2025 revenue outside the United States.

- Hawaii is the core production base and the only spirulina production site the company highlights
- Kona facility operations are central to cultivation, harvesting, and processing
- California contract manufacturers bottle and label packaged consumer products
- International markets represented 21% of fiscal 2025 revenue
- International markets represented 18% of fiscal 2024 revenue
- U.S. sales dominate, limiting foreign exchange exposure because sales are largely in USD

## Strategy

Cyanotech’s current strategy is to stabilize operations and improve cash generation while focusing on higher-margin consumer products and core ingredient lines. Management has been reducing production when demand is weak, keeping headcount and discretionary spending lower, and tightening sales and marketing execution, including strengthening eCommerce and retail capabilities. The company is also trying to improve product mix by emphasizing higher-quality spirulina and astaxanthin offerings that can support better margins. At the same time, it is using excess capacity to generate incremental revenue from contract extraction and R&D services, although those lines remain small and can be volatile.

- **Production discipline and inventory control** (short-term) — The business has high fixed agricultural costs, so matching output to demand is essential to protect cash and margins.
- **Shift toward higher-margin consumer products** (medium-term) — Premium branded supplements can support better economics than commodity-like bulk sales.
- **Monetize excess capacity** (medium-term) — Contract extraction and R&D services can generate incremental revenue from existing assets and know-how.

- Align production with demand to avoid excess inventory and cash drain
- Prioritize higher-margin consumer products and premium ingredient positioning
- Maintain reduced headcount and discretionary spending to preserve liquidity
- Strengthen eCommerce and retail execution through sales leadership changes
- Use excess extraction capacity for third-party contract services
- Leverage microalgae expertise for third-party R&D services
- Improve product mix to support profitability targets

## Risks

Cyanotech faces meaningful customer concentration risk because a small number of customers account for a large share of sales, so changes in procurement or the loss of a major account could quickly reduce revenue. Its algae cultivation model is exposed to weather, disease, contamination, water availability, and climate-related disruptions, which can reduce yields and raise unit costs. The company also operates in a highly competitive dietary supplement and ingredient market, where larger rivals and lower-cost producers in China and India can pressure pricing and share. In addition, regulatory compliance, cybersecurity, inflation, and public health disruptions can all increase costs or interrupt operations, while weak production volumes can cause fixed overhead to be expensed rather than absorbed into inventory.

- **Customer concentration** [high] — Two customers accounted for 31% and 10% of fiscal 2025 sales, so order changes by a few accounts can materially affect revenue and profitability.
- **Agricultural production variability** [high] — Microalgae cultivation depends on weather, temperature, nutrients, water, and contamination control, making output and cost absorption volatile.
- **Competitive pricing pressure** [medium] — The company competes with larger supplement producers and spirulina farms in India and China that may have greater scale or lower costs.
- **Regulatory compliance** [medium] — FDA, FTC, state health, agriculture, and environmental rules can increase costs and constrain operations or marketing claims.
- **Cybersecurity and IT disruption** [medium] — Order processing, billing, shipping, and customer support depend on information systems that could be disrupted by a breach.

- Customer concentration could cause sharp revenue declines if key accounts reduce orders
- Agricultural production risk can hurt yields through weather, disease, or contamination
- Competition from larger supplement and spirulina producers can pressure pricing
- Regulatory changes can raise compliance costs and restrict product or facility operations
- Cybersecurity incidents could disrupt order processing, billing, and customer data
- Inflation and energy cost increases can squeeze margins in a fixed-cost production model
- Public health crises can disrupt labor availability, supply chain, and demand
- Tariffs on imported biomass can reduce competitiveness of contract extraction services

## Accounting

Revenue is recognized at a point in time when control transfers, typically on delivery or customer pickup, while extraction services are recognized upon completion of the service. Because the company uses estimates for returns, coupons, trade promotions, and early payment discounts, reported revenue can move with changes in customer behavior and current business conditions. Inventory accounting is especially important because the company values inventory at the lower of cost or net realizable value and uses estimates tied to production levels, yields, potency, quality, and customer pricing; when production is below normal capacity, some fixed overhead is expensed immediately rather than capitalized. Management also highlights judgment in valuing equipment, leasehold improvements, long-lived assets, and income taxes, all of which can affect reported earnings if assumptions change.

- **Revenue recognition and variable consideration** — Net sales and gross margin
- **Inventory valuation and production absorption** — Cost of sales, inventory balance, gross profit
- **Long-lived asset impairment** — Operating income and asset carrying values
- **Income tax estimates** — Net income and effective tax rate

- Point-in-time revenue recognition affects timing of reported sales
- Variable consideration estimates affect net revenue and gross margin
- Inventory valuation depends on yields, potency, quality, and selling prices
- Under-absorption of fixed overhead can raise cost of sales when production is low
- Long-lived asset and leasehold improvement valuations can affect impairment charges
- Income tax estimates require judgment and can change with profitability

---

*Last updated: 2026-04-28T14:24:59.270067+00:00*